Heat shock protein 70 is necessary to improve mitochondrial bioenergetics and reverse diabetic sensory neuropathy following KU-32 therapys

Journal of Pharmacology and Experimental Therapeutics

Volumn 348, Issue 2, 2014, Pages 281-292

  Ma, Jiacheng ^a   Farmer, Kevin L ^a   Pan, Pan ^a   Urban, Michael J ^a   Zhao, Huiping ^a   Blagg, Brian S J ^a   Dobrowsky, Rick T ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; KU 32; NEUROPROTECTIVE AGENT; STREPTOZOCIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MITOCHONDRION; CELL ENERGY; CELL FUNCTION; CONTROLLED STUDY; DIABETIC SENSORY NEUROPATHY; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG PROTEIN BINDING; DRUG STRUCTURE; FEMALE; GENETIC MODEL; HYPOALGESIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; SENSORY NEUROPATHY; TREATMENT RESPONSE;

EID: 84893106531     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.210435     Document Type: Article

References (42)

1. Akude E, Zherebitskaya E, Chowdhury SKR, Smith DR, Dobrowsky RT, and Fernyhough P (2011) Diminished superoxide generation is associated with respiratory chain dysfunction and changes in the mitochondrial proteome of sensory neurons from diabetic rats. Diabetes 60:288-297.
2. Akude E, Zherebitskaya E, Roy Chowdhury SK, Girling K, and Fernyhough P (2010) 4-Hydroxy-2-nonenal induces mitochondrial dysfunction and aberrant axonal outgrowth in adult sensory neurons that mimics features of diabetic neuropathy. Neurotox Res 17:28-38.
3. Baseler WA, Dabkowski ER, Williamson CL, Croston TL, Thapa D, Powell MJ, Razunguzwa TT, and Hollander JM (2011) Proteomic alterations of distinct mitochondrial subpopulations in the type 1 diabetic heart: contribution of protein import dysfunction. Am J Physiol Regul Integr Comp Physiol 300:R186-R200.
4. Brand MD and Nicholls DG (2011) Assessing mitochondrial dysfunction in cells. Biochem J 435:297-312.
5. Calcutt NA, Cooper ME, Kern TS, and Schmidt AM (2009) Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials. Nat Rev Drug Discov 8:417-429.
6. Callaghan BC, Cheng HT, Stables CL, Smith AL, and Feldman EL (2012) Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol 11: 521-534.
7. Chowdhury SK, Zherebitskaya E, Smith DR, Akude E, Chattopadhyay S, Jolivalt CG, Calcutt NA, and Fernyhough P (2010) Mitochondrial respiratory chain dysfunction in dorsal root ganglia of streptozotocin-induced diabetic rats and its correction by insulin treatment. Diabetes 59:1082-1091.
8. Chowdhury SKR, Smith DR, and Fernyhough P (2013) The role of aberrant mitochondrial bioenergetics in diabetic neuropathy. Neurobiol Dis 51:56-65.
9. Chowdhury SKR, Smith DR, Saleh A, Schapansky J, Marquez A, Gomes S, Akude E, Morrow D, Calcutt NA, and Fernyhough P (2012) Impaired AMP-activated protein kinase signaling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes. Brain 135:1751-1766.
10. Coppey LJ, Davidson EP, Rinehart TW, Gellett JS, Oltman CL, Lund DD, and Yorek MA (2006) ACE inhibitor or angiotensin II receptor antagonist attenuates diabetic neuropathy in streptozotocin-induced diabetic rats. Diabetes 55:341-348.
11. Coppey LJ, Gellett JS, Davidson EP, Dunlap JA, Lund DD, and Yorek MA (2001) Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 50:1927-1937.
12. Delree P, Leprince P, Schoenen J, and Moonen G (1989) Purification and culture of adult rat dorsal root ganglia neurons. J Neurosci Res 23:198-206.
13. Evans CG, Chang L, and Gestwicki JE (2010) Heat shock protein 70 (Hsp70) as an emerging drug target. J Med Chem 53:4585-4602.
14. Farmer KL, Li C, and Dobrowsky RT (2012) Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach? Pharmacol Rev 64:880-900.
15. Fernyhough P, Roy Chowdhury SK, and Schmidt RE (2010) Mitochondrial stress and the pathogenesis of diabetic neuropathy. Expert Rev Endocrinol Metab 5:39-49.
16. Hinder LM, Vincent AM, Hayes JM, McLean LL, and Feldman EL (2013a) Apolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced neuropathy. Exp Neurol 239:102-110.
17. Hinder LM, Vivekanandan-Giri A, McLean LL, Pennathur S, and Feldman EL (2013b) Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes. J Endocrinol 216:1-11.
18. Holmström MH, Iglesias-Gutierrez E, Zierath JR, and Garcia-Roves PM (2012) Tissue-specific control of mitochondrial respiration in obesity-related insulin resistance and diabetes. Am J Physiol Endocrinol Metab 302:E731-E739.
19. Huang TJ, Price SA, Chilton L, Calcutt NA, Tomlinson DR, Verkhratsky A, and Fernyhough P (2003) Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 52:2129-2136.
20. Huang TJ, Verkhratsky A, and Fernyhough P (2005) Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons. Mol Cell Neurosci 28:42-54.
21. Huang Y-T and Blagg BSJ (2007) A library of noviosylated coumarin analogues. J Org Chem 72:3609-3613.
22. Jack MM, Ryals JM, and Wright DE (2011) Characterisation of glyoxalase I in a streptozocin-induced mouse model of diabetes with painful and insensate neuropathy. Diabetologia 54:2174-2182.
23. Li C, Ma J, Zhao H, Blagg BSJ, and Dobrowsky RT (2012) Induction of heat shock protein 70 (Hsp70) prevents neuregulin-induced demyelination by enhancing the proteasomal clearance of c-jun. ASN Neuro 4:e00102.
24. Matts RL, Brandt GE, Lu Y, Dixit A, Mollapour M, Wang S, Donnelly AC, Neckers L, Verkhivker G, and Blagg BS (2011) A systematic protocol for the characterization of Hsp90 modulators. Bioorg Med Chem 19:684-692.
25. McGuire JF, Rouen S, Siegfreid E, Wright DE, and Dobrowsky RT (2009) Caveolin-1 and altered neuregulin signaling contribute to the pathophysiological progression of diabetic peripheral neuropathy. Diabetes 58:2677-2686.
26. Morimoto RI (2011) The heat shock response: systems biology of proteotoxic stress in aging and disease. Cold Spring Harb Symp Quant Biol 76:91-99.
27. Muchowski PJ and Wacker JL (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6:11-22.
28. Oltman CL, Davidson EP, Coppey LJ, Kleinschmidt TL, Lund DD, Adebara ET, and Yorek MA (2008) Vascular and neural dysfunction in Zucker diabetic fatty rats: a difficult condition to reverse. Diabetes Obes Metab 10:64-74.
29. Ouyang YB, Xu LJ, Sun YJ, and Giffard RG (2006) Overexpression of inducible heat shock protein 70 and its mutants in astrocytes is associated with maintenance of mitochondrial physiology during glucose deprivation stress. Cell Stress Chaperones 11:180-186.
30. Peterson LB and Blagg BS (2009) To fold or not to fold: modulation and consequences of Hsp90 inhibition. Future Med Chem 1:267-283.
31. Sansbury BE, Jones SP, Riggs DW, Darley-Usmar VM, and Hill BG (2011) Bioenergetic function in cardiovascular cells: the importance of the reserve capacity and its biological regulation. Chem Biol Interact 191:288-295.
32. Santos JM, Tewari S, Goldberg AFX, and Kowluru RA (2011) Mitochondrial biogenesis and the development of diabetic retinopathy. Free Radic Biol Med 51:1849-1860.
33. Schmidt O, Pfanner N, and Meisinger C (2010) Mitochondrial protein import: from proteomics to functional mechanisms. Nat Rev Mol Cell Biol 11:655-667.
34. Tomlinson DR and Gardiner NJ (2008) Glucose neurotoxicity. Nat Rev Neurosci 9:36-45.
35. Urban MJ, Li C, Yu C, Lu Y, Krise JM, McIntosh MP, Rajewski RA, Blagg BSJ, and Dobrowsky RT (2010) Inhibiting heat-shock protein 90 reverses sensory hypoalgesia in diabetic mice. ASN Neuro 2:e00040.
36. Urban MJ, Pan P, Farmer KL, Zhao H, Blagg BS, and Dobrowsky RT (2012) Modulating molecular chaperones improves sensory fiber recovery and mitochondrial function in diabetic peripheral neuropathy. Exp Neurol 235:388-396.
37. Vincent AM, Hayes JM, McLean LL, Vivekanandan-Giri A, Pennathur S, and Feldman EL (2009) Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1. Diabetes 58:2376-2385.
38. Wang L, Schumann U, Liu Y, Prokopchuk O, and Steinacker JM (2012) Heat shock protein 70 (Hsp70) inhibits oxidative phosphorylation and compensates ATP balance through enhanced glycolytic activity. J Appl Physiol 113:1669-1676.
39. Wright DE, Johnson MS, Arnett MG, Smittkamp SE, and Ryals JM (2007) Selective changes in nocifensive behavior despite normal cutaneous axon innervation in leptin receptor-null mutant (db/db) mice. J Peripher Nerv Syst 12:250-261.
40. Xu L, Emery JF, Ouyang Y-B, Voloboueva LA, and Giffard RG (2010) Astrocyte targeted overexpression of Hsp72 or SOD2 reduces neuronal vulnerability to forebrain ischemia. Glia 58:1042-1049.
41. Zhang L, Zhao H, Blagg BS, and Dobrowsky RT (2012) C-terminal heat shock protein 90 inhibitor decreases hyperglycemia-induced oxidative stress and improves mitochondrial bioenergetics in sensory neurons. J Proteome Res 11:2581-2593.
42. Zhao H, Michaelis ML, and Blagg BS (2012) Hsp90 modulation for the treatment of Alzheimer's disease. Adv Pharmacol 64:1-25.